BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15135249)

  • 21. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida.
    Wilson A; Platt R; Wu Q; Leclerc D; Christensen B; Yang H; Gravel RA; Rozen R
    Mol Genet Metab; 1999 Aug; 67(4):317-23. PubMed ID: 10444342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank.
    Yang QH; Botto LD; Gallagher M; Friedman JM; Sanders CL; Koontz D; Nikolova S; Erickson JD; Steinberg K
    Am J Clin Nutr; 2008 Jul; 88(1):232-46. PubMed ID: 18614746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MTRR 66A>G polymorphism in relation to congenital heart defects.
    van Beynum IM; Kouwenberg M; Kapusta L; den Heijer M; van der Linden IJ; Daniels O; Blom HJ
    Clin Chem Lab Med; 2006; 44(11):1317-23. PubMed ID: 17087642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of homocysteine (but not of MTHFR 677 C>T, MTR 2756 A>G, MTRR 66 A>G and TCN2 776 C>G) with ischaemic cerebrovascular disease in Sicily.
    Bosco P; Guéant-Rodriguez RM; Anello G; Spada R; Romano A; Fajardo A; Caraci F; Ferri R; Guéant JL
    Thromb Haemost; 2006 Aug; 96(2):154-9. PubMed ID: 16894458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotypes of the MTHFR C677T and MTRR A66G genes act independently to reduce migraine disability in response to vitamin supplementation.
    Menon S; Lea RA; Roy B; Hanna M; Wee S; Haupt LM; Oliver C; Griffiths LR
    Pharmacogenet Genomics; 2012 Oct; 22(10):741-9. PubMed ID: 22926161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes.
    Wiltshire EJ; Mohsin F; Chan A; Donaghue KC
    Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):348-53. PubMed ID: 18774994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects.
    Zijno A; Andreoli C; Leopardi P; Marcon F; Rossi S; Caiola S; Verdina A; Galati R; Cafolla A; Crebelli R
    Carcinogenesis; 2003 Jun; 24(6):1097-103. PubMed ID: 12807760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperhomocysteinemia and assessment of its associated factors in renal transplant recipients: a single-center study in northern Iran.
    Monfared A; Azimi SZ; Kazemnezhad E; Khosravi M; Lebadi M; Mirzajani E; Ashtiani MN
    Transplantation; 2014 Jul; 98(1):66-71. PubMed ID: 24978036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms predisposing to hyperhomocysteinemia in cardiac transplant patients.
    Miriuka SG; Langman LJ; Evrovski J; Miner SE; D'Mello N; Delgado DH; Wong BY; Ross HJ; Cole DE
    Transpl Int; 2005 Jan; 18(1):29-35. PubMed ID: 15612980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption.
    Ananth CV; Elsasser DA; Kinzler WL; Peltier MR; Getahun D; Leclerc D; Rozen RR;
    Mol Genet Metab; 2007 May; 91(1):104-10. PubMed ID: 17376725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
    Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Riboflavin status modifies the effects of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) polymorphisms on homocysteine.
    García-Minguillán CJ; Fernandez-Ballart JD; Ceruelo S; Ríos L; Bueno O; Berrocal-Zaragoza MI; Molloy AM; Ueland PM; Meyer K; Murphy MM
    Genes Nutr; 2014 Nov; 9(6):435. PubMed ID: 25322900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.
    Gaughan DJ; Kluijtmans LA; Barbaux S; McMaster D; Young IS; Yarnell JW; Evans A; Whitehead AS
    Atherosclerosis; 2001 Aug; 157(2):451-6. PubMed ID: 11472746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.
    Jacques PF; Bostom AG; Selhub J; Rich S; Ellison RC; Eckfeldt JH; Gravel RA; Rozen R;
    Atherosclerosis; 2003 Jan; 166(1):49-55. PubMed ID: 12482550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives.
    Ozbek Z; Kucukali CI; Ozkok E; Orhan N; Aydin M; Kilic G; Sazci A; Kara I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1331-7. PubMed ID: 18513846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
    Ventura P; Panini R; Emiliani S; Salvioli G
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of congenital heart defects is influenced by genetic variation in folate metabolism.
    Christensen KE; Zada YF; Rohlicek CV; Andelfinger GU; Michaud JL; Bigras JL; Richter A; Dubé MP; Rozen R
    Cardiol Young; 2013 Feb; 23(1):89-98. PubMed ID: 22475273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and environmental influences on total plasma homocysteine and coronary artery disease (CAD) risk among South Indians.
    Vinukonda G; Shaik Mohammad N; Md Nurul Jain J; Prasad Chintakindi K; Rama Devi Akella R
    Clin Chim Acta; 2009 Jul; 405(1-2):127-31. PubMed ID: 19394322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C677T polymorphism of the methylenetetrahydrofolate reductase gene does not affect folic acid, vitamin B12, and homocysteine serum levels in Turkish children with neural tube defects.
    Erdogan MO; Yildiz SH; Solak M; Eser O; Cosar E; Eser B; Koken R; Buyukbas S
    Genet Mol Res; 2010 Jun; 9(2):1197-203. PubMed ID: 20589617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.